Cases
Representative Matters: Mergers
Acquisitions Represented provider of electric utility billing & data management services, energy portfolio management,
energy procurement strategies in its sale to a leading private equity firm.
Represented the largest privately held nursing company in its 40M acquisition of a national provider of healthcare workforce solutions.
Represented consumer products manufacturer in its 30M sale to a large, private equity-backed, strategic buyer.
Represented manufacturer of custom cable solutions in its 25M sale to a global strategic buyer.
Represented majority owner of a real estate development
management platform in its sale to a strategic buyer for 23M.
Represented owners of regional food
beverage franchise chain in a 30M sale to a large private equity fund.
Represented private equity sponsor in its majority acquisition of a pet food company.
Represented medical supply company in its 160M sale to a leading healthcare private equity firm.
Represented behavioral health company in its 33M sale to a leading private equity construction firm.
Represented leasing platform housing company in its 250M sale to a leading Nasdaq provider of real estate software
data analytics company.
Represented golf simulation company in its 30M sale to a private equity firm
golf manufacturing company.
Represented Nasdaq software simulation company in its acquisition of a clinical trial data analysis company
a drug -induced liver analysis company valued at over 15M.
Represented Irish pharmaceutical company in 2.5B merger with a NASDAQ pharmaceutical company.
Represented management in their 165M buyout of the US operations of a large London Stock Exchange homebuilder, which included a separately negotiated 60M private financing component.
Represented medical device manufacturer in its 30M sale to German acquirer.
Represented transportation company in its 27M acquisition by a private equity fund.
Represented NYSE company in acquisition of 50 cash advance companies in Southern California.
Represented Italian biotech company in significant licensing/stock deal with NASDAQ biopharma company.
Represented large privately held international life-sciences company in connection with the 95M sale of its,
its subsidiaries, outst
ing capital stock to a global provider of biological products
enabling technologies listed on the NASDAQ national stock market.
Represented a large state pension fund in connection with the disposition of its approximately 70M investment in two international real estate funds.
Represented a subsidiary of a large publicly-traded homebuilder in connection with the approximately 48M acquisition of all of the outst
ing equity of a local developer.
Represented a leading wholesale distributor in connection with strategic acquisitions totaling more than 45M.
Represented large privately held foreign corporation in connection with its 30M acquisition of US-based software company.
Represented Internet-based information technology company in connection with its 30M acquisition by a large strategic partner.
Represented manufacturer of telecommunications equipment in connection with the approximately 25M acquisition of all of its outst
ing equity to the US subsidiary of a large international conglomerate.
Represented manufacturer in aerospace industry in connection with the sale of all of its outst
ing equity for approximately 20M to a private equity fund. Financings Represented high end hunting gear company in its 50M sale of minority interest to leading private consumer growth equity firm.
Represented leading alternative creamer in its Series B Preferred round led by large private equity fund.
Represented leading beverage company in its Series D Preferred round led by large private equity fund.
Represented Irish biotechnology company in 87M secondary public offering of shares in a NASDAQ biopharmaceutical company.
Represented one of a group of investors in connection with the 500M financing of a production company.
Represented a pharmaceutical company listed on NASDAQ in connection with 45M of PIPE financings.
Represented a private company providing tools to foster safer driving
to aid in crash reconstruction in connection with an offering of Series D Preferred Stock to investors for approximately 41M.
Represented one of a group of investors in connection with the 40.5M financing of an AMEX listed pharmaceutical company.
Represented underwriter in connection with a 15M firmly underwritten public offering.
Represented provider of interactive digital broadb
services in connection with 15M financing by several institutional investors led by NYSE listed company.
